TAL1 Antikörper (C-Term)
Kurzübersicht für TAL1 Antikörper (C-Term) (ABIN7469624)
Target
Alle TAL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human TAL1. The exact sequence is proprietary.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:3000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Kommentare
-
Validation: Orthogonal
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.61 mg/mL
-
Buffer
- 1XPBS pH 7, 20 % Glycerol, 0.025 % ProClin 300
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
-
Andere Bezeichnung
- TAL1
-
Hintergrund
- TAL bHLH transcription factor 1, erythroid differentiation factor , SCL , TCL5 , bHLHa17 , tal-1
-
Molekulargewicht
- 34 kDa
-
Gen-ID
- 6886
-
UniProt
- P17542
-
Pathways
- Stem Cell Maintenance
Target
-